LIVE FROM THE DATABASETRANSACTIONS 723,671COMPANIES 6,572LATEST TRADE Oct 27UPDATED Oct 28, 01:30 PM
Reporting ownerCIK 0001777413

Mark Lackner

4 transactions in one company, from January 2, 2025 to February 3, 2025.

Transactions
41 company
Bought · P
$0open market
Sold · S
$38Kopen market
Net
−$38Knet selling

By company

Where this insider traded.

CompanyTickerTradesBoughtSold
Zentalis Pharmaceuticals, Inc.ZNTL4—$38K

All transactions

4 in total, newest filings first.

CompanyTickerInsiderDateCodeSharesPriceValueHeld after
Zentalis Pharmaceuticals, Inc.ZNTLMark LacknerChiefDERIVFeb 3AAward124,714$0.00—?124,714derivatives
Zentalis Pharmaceuticals, Inc.ZNTLMark LacknerChiefFeb 3S14,368$1.71$25K512,856
Zentalis Pharmaceuticals, Inc.ZNTLMark LacknerChiefFeb 3AAward335,907$0.00—527,224
Zentalis Pharmaceuticals, Inc.ZNTLMark LacknerChiefJan 2S4,411$3.12$14K191,317